An interventional study of PNM in Neuromodulation, Anterior Pain Knee and Femoral Nerve, sponsored by University of Seville. Completed at 1 site in Spain. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2020-07-14.
Sponsored by University of Seville · Not applicable, Interventional, and Treatment
Anterior knee pain (AKP) is one of the most frequent pathologies of the lower limb, in young and adult subjects. In the field of Physiotherapy, ultrasound-guided Percutaneous Neuromodulation (PNM) is defined as the application through a needle with ultrasound guidance of an electrical current at low or medium frequency, seeking a sensitive and / or motor response of a peripheral nerve in some point of its trajectory, or of a muscle in a motor point, with a therapeutic objective. The objective of this study is to analyze that the effect of PNM on the femoral nerve produces statistically significant changes in pain, joint range and knee functionality in patients with chronic AKP. Thirty subjects will be recruited, which will be divided into 2 groups: group 1 to which PNM will be applied to the femoral nerve of the pain knee; and group 2 to which PNM will be applied to the femoral nerve of the non-pain knee. The PNM intervention with NMP will consist in the single application of an asymmetric rectangular biphasic current (250 microseconds, 10 Hz)
University of Seville is the lead sponsor of 127 studies on the registry; 37 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
participants in whom PNM will be applied to the femoral nerve of the pain knee
Other: PNM
participants in whom PNM will be applied to the femoral nerve of the non-pain knee
Other: PNM
an asymmetric rectangular biphasic current (250 microseconds, 10 Hz)
visual analog scale (VAS) (0, no pain; 100, maximum pain).
pain
Time frame: up to 1 week
range joint
goniometer
Time frame: up to 1 week
VISA-p questionnaire (0, maximum pain; 100, no pain).
Functional pain
Time frame: up to 1 week
Kujala questionnaire (0, maximum pain; 100, no pain).
Functional pain
Time frame: up to 1 week
This study is completed, as verified in Jul 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Seville